// App-Quantinova.ai

3027 : Reduced-Intensity Versus Myeloablative Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 45 Years with Acute Lymphoblastic Leukemia (ALL) in Remission: A Study From the ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT).

Researchers

Presenter

  • Kanamori Heiwa

Principal Investigators

  • Nishiwaki Satoshi

  • Hisashi Sakamaki

  • Nishimoto Naoki

  • Nobuo Masauzi

  • Ohashi Kazuteru

  • Taniguchi Shuichi

  • Eto Tetsuya

  • Nakamae Hirohisa

  • Yoshio Katayama

  • Yasuo Morishima

  • Ritsuro Suzuki

  • Koji Kato

Medical Centers

  • HSCT Data Management, Nagoya University Sch. of Med., Nagoya, Japan

  • Department of Pathologic Oncology, Mie University Graduate School of Medicine, Mie, Japan

  • Division of Pediatric Hematology/Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan

  • Department of Radiology, Okayama University Graduate School of Medicine, Okayama, Japan

  • Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka City, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

Biomarkers

  • Breakpoint Cluster Region

  • Soluble Complement 5b-9

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • fludarabine tablet

  • Melphalan

  • Busulfan

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved